Global Non-benzodiazepine Hypnotics Market Growth 2025-2031

The global Non-benzodiazepine Hypnotics market size is predicted to grow from US$ 1351 million in 2025 to US$ 1851 million in 2031; it is expected to grow at a CAGR of 5.4% from 2025 to 2031.

Non-benzodiazepine hypnotics are a class of drugs used to treat insomnia, which share similar effects to benzodiazepines but have a different chemical structure. Common non-benzodiazepine hypnotics include zopiclone, zaleplon, and eszopiclone. These drugs have sedative and hypnotic effects but are generally less likely to cause dependence or tolerance, making them widely used in clinical practice for the treatment of insomnia.

United States market for Non-benzodiazepine Hypnotics is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.

China market for Non-benzodiazepine Hypnotics is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.

Europe market for Non-benzodiazepine Hypnotics is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.

Global key Non-benzodiazepine Hypnotics players cover Sanofi-aventis, Hikma Pharmaceuticals, Northstar Rx, Teva Pharmaceuticals, Torrent Pharma, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2024.

LP Information, Inc. (LPI) ' newest research report, the “Non-benzodiazepine Hypnotics Industry Forecast” looks at past sales and reviews total world Non-benzodiazepine Hypnotics sales in 2024, providing a comprehensive analysis by region and market sector of projected Non-benzodiazepine Hypnotics sales for 2025 through 2031. With Non-benzodiazepine Hypnotics sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Non-benzodiazepine Hypnotics industry.

This Insight Report provides a comprehensive analysis of the global Non-benzodiazepine Hypnotics landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Non-benzodiazepine Hypnotics portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Non-benzodiazepine Hypnotics market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Non-benzodiazepine Hypnotics and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Non-benzodiazepine Hypnotics.

This report presents a comprehensive overview, market shares, and growth opportunities of Non-benzodiazepine Hypnotics market by product type, application, key manufacturers and key regions and countries.

Segmentation by Type:
Zolpidem
Zopiclone
Zaleplon
Other

Segmentation by Application:
Hospital
Clinic
Other

This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analysing the company's coverage, product portfolio, its market penetration.
Sanofi-aventis
Hikma Pharmaceuticals
Northstar Rx
Teva Pharmaceuticals
Torrent Pharma
Apotex
Endo
Mylan Pharmaceuticals
Abbott
Sun Pharmaceutical
Tapi Teva
Admiron Life
Dr. Reddy’s Laboratories
Shanghai Pharmaceuticals
Kanghong Pharmaceutical
Glenmark Life Sciences
Wockhardt
Centaur Pharmaceuticals
Tianjin Tasly Saint Pharmaceuticals
Kanghong Pharmaceuticals
Qilu Pharmaceutical
Changzhou Siyao Pharmaceutical

Key Questions Addressed in this Report

What is the 10-year outlook for the global Non-benzodiazepine Hypnotics market?

What factors are driving Non-benzodiazepine Hypnotics market growth, globally and by region?

Which technologies are poised for the fastest growth by market and region?

How do Non-benzodiazepine Hypnotics market opportunities vary by end market size?

How does Non-benzodiazepine Hypnotics break out by Type, by Application?

Please note: The report will take approximately 2 business days to prepare and deliver.